Insider Transactions in Q2 2024 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2024
|
Dawn Halkuff Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.75%
|
-
|
|
Jun 05
2024
|
Garheng Kong Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+23.35%
|
-
|
|
Jun 05
2024
|
Marla Persky Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.75%
|
-
|
|
Jun 05
2024
|
John Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.31%
|
-
|
|
Jun 05
2024
|
Barbara Jean Anne Bormann Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.75%
|
-
|
|
Jun 05
2024
|
Jeffrey W Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+23.32%
|
-
|
|
Jun 05
2024
|
Ricki Louise Fairley Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+27.03%
|
-
|
|
Jun 05
2024
|
John P. Schmid Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+30.65%
|
-
|
|
May 10
2024
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
5,400
+24.77%
|
$5,400
$1.91 P/Share
|